These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10497116)

  • 21. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface.
    Bonaldo MC; Garratt RC; Marchevsky RS; Coutinho ES; Jabor AV; Almeida LF; Yamamura AM; Duarte AS; Oliveira PJ; Lizeu JO; Camacho LA; Freire MS; Galler R
    J Virol; 2005 Jul; 79(13):8602-13. PubMed ID: 15956601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells.
    Brandler S; Brown N; Ermak TH; Mitchell F; Parsons M; Zhang Z; Lang J; Monath TP; Guirakhoo F
    Am J Trop Med Hyg; 2005 Jan; 72(1):74-81. PubMed ID: 15728870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
    Hahn CS; Dalrymple JM; Strauss JH; Rice CM
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2019-23. PubMed ID: 3470774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses.
    Collins ND; Beck AS; Widen SG; Wood TG; Higgs S; Barrett ADT
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates.
    McGee CE; Lewis MG; Claire MS; Wagner W; Lang J; Guy B; Tsetsarkin K; Higgs S; Decelle T
    J Infect Dis; 2008 Mar; 197(5):693-7. PubMed ID: 18266603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
    Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
    PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice.
    Gibson CA; Wills MR; Gould EA; Sanders PG; Barrett AD
    Vaccine; 1990 Dec; 8(6):590-4. PubMed ID: 2128429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    Schlesinger JJ; Brandriss MW; Walsh EE
    J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX; Ni H; Wills MR; Campbell GA; Sil BK; Ryman KD; Kitchen I; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation among strains of wild-type yellow fever virus from Senegal.
    Wang H; Jennings AD; Ryman KD; Late CM; Wang E; Ni H; Minor PD; Barrett AD
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1349-52. PubMed ID: 9191928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain.
    Schlesinger JJ; Chapman S; Nestorowicz A; Rice CM; Ginocchio TE; Chambers TJ
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1277-85. PubMed ID: 8683217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.
    Chambers TJ; Nickells M
    J Virol; 2001 Nov; 75(22):10912-22. PubMed ID: 11602731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.
    Ryman KD; Ledger TN; Weir RC; Schlesinger JJ; Barrett AD
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1353-6. PubMed ID: 9191929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants of Yellow Fever Virus pathogenicity in Syrian Golden Hamsters: one mutation away from virulence.
    Klitting R; Roth L; Rey FA; de Lamballerie X
    Emerg Microbes Infect; 2018 Mar; 7(1):51. PubMed ID: 29593212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.